Clinical Trials Browser

Phase 1 × Withdrawn × Hyaluronoglucosaminidase × Clear all

NCT07082270 2026-04-15

Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma

Phase 1 Withdrawn

Multiple Myeloma